Compounds > cholestyramine resin
Page last updated: 2024-09-03

cholestyramine resin and clofibric acid

cholestyramine resin has been researched along with clofibric acid in 9 studies

Compound Research Comparison

Studies
(cholestyramine resin)		Trials
(cholestyramine resin)		Recent Studies (post-2010)
(cholestyramine resin)		Studies
(clofibric acid)		Trials
(clofibric acid)		Recent Studies (post-2010) (clofibric acid)
2,6693421901,429103120

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19905 (55.56)18.7374
1990's2 (22.22)18.2507
2000's2 (22.22)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ebisuno, S; Isohashi, F; Nakanishi, Y; Sakamoto, Y1
Canzler, H1
von Bock und Polach, U1
Kolb, S; Sailer, D1
Baldwin, JR; Feller, DR; Witiak, DT1
Krüger, B1
Farmer, JA; Gotto, AM1
Birbeck, GL; Jacobs, BS; Kothari, RU; Maddox, K; Mullard, AJ; Reeves, MJ; Stoeckle-Roberts, S; Wehner, S1
Balbisi, EA1

Reviews

2 review(s) available for cholestyramine resin and clofibric acid

ArticleYear
Antihyperlipidaemic agents. Drug interactions of clinical significance.
    Drug safety, 1994, Volume: 11, Issue:5

    Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibric Acid; Colestipol; Drug Interactions; Fibric Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Niacin; Probucol

1994
Management of hyperlipidemia: new LDL-C targets for persons at high-risk for cardiovascular events.
    Medical science monitor : international medical journal of experimental and clinical research, 2006, Volume: 12, Issue:2

    Topics: Azetidines; Cardiovascular Diseases; Cholesterol, LDL; Cholestyramine Resin; Clofibric Acid; Drug Therapy, Combination; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Life Style; Niacin; Risk Factors

2006

Other Studies

7 other study(ies) available for cholestyramine resin and clofibric acid

ArticleYear
Acetyl-CoA hydrolase: relation between activity and cholesterol metabolism in rat.
    The American journal of physiology, 1988, Volume: 255, Issue:5 Pt 2

    Topics: Acetyl-CoA Hydrolase; Animals; Anticholesteremic Agents; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Clofibric Acid; Cytosol; Diabetes Mellitus, Experimental; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Male; Naphthalenes; Pravastatin; Rats; Thiolester Hydrolases

1988
[Drug therapy of hypercholesterinemias (author's transl)].
    MMW, Munchener medizinische Wochenschrift, 1980, Mar-28, Volume: 122, Issue:13

    Topics: Adult; Bezafibrate; Cholestyramine Resin; Clofibric Acid; Colestipol; Dextrothyroxine; Fenofibrate; Humans; Hypercholesterolemia; Neomycin; Nicotinic Acids; Sitosterols

1980
[Lowering lipids rapidly and permanently with etofibrate].
    Medizinische Klinik, 1982, Jan-29, Volume: 77, Issue:3

    Topics: Cholestyramine Resin; Clofibrate; Clofibric Acid; Dextrothyroxine; Humans; Hyperlipoproteinemias; Lipoproteins, HDL; Liver; Nicotinic Acids; Sitosterols

1982
[Treatment of coronary heart disease with diet and lipid-reducing agents].
    Fortschritte der Medizin, 1982, Nov-18, Volume: 100, Issue:43

    Topics: Adolescent; Adult; Child; Cholestyramine Resin; Clofibrate; Clofibric Acid; Colestipol; Coronary Disease; Dextrothyroxine; Humans; Hypolipidemic Agents; Nicotinic Acids; Risk

1982
Disposition of clofibrate in the rat. Acute and chronic administration.
    Biochemical pharmacology, 1980, Dec-01, Volume: 29, Issue:23

    Topics: Animals; Bile; Cholesterol; Cholestyramine Resin; Clofibrate; Clofibric Acid; Ethylmorphine; Feces; Male; Microsomes, Liver; Phenobarbital; Rats; Subcellular Fractions; Tissue Distribution; Triglycerides

1980
Etofibrate therapy and effect of added low-dose cholestyramine in patients with combined hyperlipidaemia.
    International journal of clinical pharmacology research, 1994, Volume: 14, Issue:5-6

    Topics: Adult; Aged; Apolipoproteins; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Clofibric Acid; Drug Synergism; Drug Therapy, Combination; Female; Fibrinogen; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoprotein(a); Male; Middle Aged; Practice Guidelines as Topic; Triglycerides

1994
Lipid testing and lipid-lowering therapy in hospitalized ischemic stroke and transient ischemic attack patients: results from a statewide stroke registry.
    Stroke, 2006, Volume: 37, Issue:1

    Topics: Aged; Anticoagulants; Cholestyramine Resin; Clofibric Acid; Female; Hospital Records; Hospitalization; Hospitals; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemia; Ischemic Attack, Transient; Lipids; Male; Middle Aged; Models, Statistical; Niacin; Registries; Risk Factors; Stroke

2006